Suven Life Sciences has informed that the Board of Directors of the Company at its meeting held today 28th March, 2022 has approved the conversion of 1,81,00,000 fully paid warrants and issued & allotted 1,81,00,000 (One crore eighty one lakh) Equity Shares of Re 1 each to 'Jasti Property and Equity Holdings (In its capacity as sole trustee of Jasti Family Trust)', promoter group entity at an issue price of Rs 81.57 per share on preferential basis in accordance with SEBI (Issue of Capital and
Disclosure Requirements) Regulations, 2018.
The above information is a part of company’s filings submitted to BSE.
